TY  - GEN
AU  - Stopeck,Alison T
AU  - Unger,Joseph M
AU  - Rimsza,Lisa M
AU  - Bellamy,William T
AU  - Iannone,Maria
AU  - Persky,Daniel O
AU  - Leblanc,Michael
AU  - Fisher,Richard I
AU  - Miller,Thomas P
TI  - A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
SN  - 1029-2403
PY  - 2009///0827
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Bevacizumab
KW  - Biomarkers
KW  - analysis
KW  - Disease-Free Survival
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - drug therapy
KW  - Lymphoma, Mantle-Cell
KW  - Lymphoma, Non-Hodgkin
KW  - Male
KW  - Middle Aged
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Salvage Therapy
KW  - methods
KW  - Southwestern United States
KW  - Vascular Cell Adhesion Molecule-1
KW  - blood
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1080/10428190902856808
ER  -